Home Obi Profile Fees Services News Publications Contact  
You are here: Title Details
Search  
    Login
Inventions Industrial DesignTechnological Information
ANTITUMOR AGENT INCLUDING IRINOTECAN HYDROCHLORIDE HYDRATE

No-Receipt date 2020-03654 - 02/10/2020
No-Filing date 20200402742 - 02/10/2020
No-Granting date 3105131 - 13/10/2020
No-EPO application date 14773672.2 - 27/03/2014
No-EPO granting date 2979701 - 26/08/2020
Gazette No-Publication date of application -
Gazette No-Publication date of granted patent 10/2020 - 16/11/2020
Expiration date 28/03/2034
Kind of title Validation of European Patent
Legal status VALID
Priorities JP201306607327/03/2013/JP
Active Substance of Supplementary Certificates -

IPC Classification
Ipc Class
A61P 43/00
A61P 35/00
A61K 31/7072
A61K 31/506
A61K 31/4745

Related Documents

Related Titles

Owners
CodeFirstnameSurnameAddressTownZIPCountry
1231385 TAIHO PHARMACEUTICAL CO., LTD. 1-27, KANDANISHIKI-CHOCHIYODA-KU, TOKYO 101-8444 JAPAN

Inventors
CodeFirstnameSurname
3138216 OKABE, HIROYUKI

Representatives
CodeFirstnameSurnameAddressTownZip
3712ANTHOULAGALANOPOULOUTHESI LYSI MPITAKOUKAPANDRITI (ATTIKIS)19014

Contact
CodeFirstnameSurnameAddressTownZipCountry
9219ALKISTIS-EIRINIMALAMIVISSARIONOS 3ATHINA (ATTIKIS)10672 GREECE

Owners History

Title Instruments

Payments history 12 renewals have been done
Print
Dues Online PaymentNational Patent RegisterOne Stop Shop (OSS)
© OBI all rights reserved designed & developed by PROFILE S.A.
Certified QMS : EN ISO 9001:2015 and ΕΝ ISO 14001:2015